Viewing Study NCT01688492


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2025-12-26 @ 5:03 AM
Study NCT ID: NCT01688492
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-12
First Post: 2012-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDX-010 (Ipilimumab) View
None ABIRATERONE ACETATE (CB 7630) View
None PREDNISONE View
None Immunotherapy-naïve View
None castration resistant prostate cancer (CRPC) View
None 12-120 View